Why should business fund gene therapies?

You don’t know if this will be your story someday. You can build a company for decades. You can plan for growth, investments, and expansion. But you can’t plan for one thing: will a child come into your life who needs therapy that doesn’t exist today?

Today, you have a say in whether such therapy will be created.

Policy for generations

Your company is funding AAV technology that could save your children, grandchildren, and team in the future. This is the ultimate form of CSR – saving lives.

Innovation and prestige

Stand alongside global giants. Supporting groundbreaking research positions your brand as a leader in the modern world (High-Tech Philanthropy).

Measurable Impact

We report on every progress. You’ll see your funds transformed into concrete scientific publications and the first successful clinical trials.

Why do brands of the future invest in breakthrough discoveries?

Brands of the future don’t wait for the future to arrive. They know that real change begins where courage meets science, technology, and long-term vision. By investing in breakthroughs, they help accelerate solutions that can transform the lives of millions. This isn’t just support, but a decision to become part of history that is still being written.

Legacy & Branding

Go down in history as a patron of breakthroughs. Your logo will be alongside discoveries worthy of a Nobel Prize.

Employer Branding 3.0

Przyciągnij talenty z Gen Z i Millenialsów. Pokaż swoim pracownikom, że ich praca realnie zmienia losy świata.

Networking & Innovations

Join an elite group of partners. Gain access to proprietary reports on biotechnology progress and meetings with top scientists.

Contact for companies

Science provides the tools, family stories provide the reason. Your company offers the opportunity for these two worlds to come together and save lives.

Fundacja Purestone
Rynek 60/2
50-116 Wrocław
Poland
Legal status: Foundation
NIP: 8971783925
Regon: 021843765
KRS: 0000413907
PBO status: as of 29.04.2015.